Soldiers suffering from traumatic brain injury (TBI) caused by an explosive blast had a higher rate of anterior pituitary dysfunction than people who sustained a non-blast TBI, suggesting pituitary dysfunction is a particular problem after blast exposure, according to a study published online Sept. 24 in Annals of Neurology.

Patients with symptoms of Alzheimer’s disease (AD) who are diagnosed early with PET imaging receive medication earlier and have better clinical outcomes, according to interim results from the first study to confirm the benefits of early diagnosis in the neurodegenerative disease.

According to the Alzheimer's Disease International 2013 World Alzheimer's Report, "Journey of Caring," care associated with Alzheimer's disease and other forms of dementia is a global issue that must be addressed as prevalence and costs continue to soar, placing enormous stress on families and nations alike.

A new drug to treat Alzheimer’s disease would obviously impact the lives of millions of people in the U.S. affected by the disease. Any significant breakthrough could also mean tens of billions of dollars for the pharmaceutical company that makes it.

The National Football League (NFL) will pay more than $750 million to settle a lawsuit brought by retired players who argued the league didn’t do enough to protect players from concussions, according to the terms of a tentative settlement announced Aug. 29.

Sports news giant ESPN has ended its participation in a joint reporting project with PBS’ Frontline that was focused on concussions in the National Football League.

Giving new meaning to the phrase “mind reader,” Dutch researchers have demonstrated a functional imaging method that allows them to read characters viewed by a test subject.

Amyloid beta and tau pathologies appear to be associated with default mode network (DMN) integrity before clinical onset of Alzheimer’s disease (AD), according to a study published online Aug. 19 in JAMA Neurology.